Voelkle, 57 patient zinc sufficiency study: 77% lower combined mortality/ICU admission [p=0.007] https://c19p.org/voelklez
copied to clipboard
Prevalence of Micronutrient Deficiencies in Patients Hospitalized with COVID-19: An Observational Cohort Study
et al., Nutrients, doi:10.3390/nu14091862
Prospective study of 57 consecutive hospitalized COVID-19 patients in Switzerland, showing higher risk of mortality/ICU admission with vitamin A, vitamin D, and zinc deficiency, with statistical significance only for vitamin A and zinc. Adjustments only considered age.
|
risk of death/ICU, 77.1% lower, RR 0.23, p = 0.007, high zinc levels 5 of 35 (14.3%), low zinc levels 10 of 22 (45.5%), NNT 3.2, adjusted per study, odds ratio converted to relative risk.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Voelkle et al., 4/30/2022, prospective, Switzerland, Europe, peer-reviewed, median age 67.0, 9 authors, study period 17 March, 2020 - 30 April, 2020.
Contact:
schuetzph@gmail.com (corresponding author), manyola.voelkle@ksa.ch, claudia.gregoriano@ksa.ch, daniel.koch@ksa.ch, alexander.kutz@ksa.ch, beat.mueller@ksa.ch, anna.conen@ksa.ch, peter.neyer@ksa.ch, luca.bernasconi@ksa.ch.
voelkle
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.